Years af­ter link­ing arms with Bris­tol My­ers and both Mer­cks, Sutro finds its lat­est part­ner in Tokyo

Astel­las and Sutro Bio­phar­ma are link­ing arms on a new field of an­ti­body-drug con­ju­gates that they hope will im­prove up­on ex­ist­ing can­cer im­munother­a­pies.

The Tokyo …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER